These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6168852)

  • 1. Comparison of the time course of action of captopril on angiotensin-converting enzyme with the time course of its antihypertensive effect.
    Velletri P; Bean BL
    J Cardiovasc Pharmacol; 1981; 3(5):1068-81. PubMed ID: 6168852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
    Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
    Waeber B; Brunner HR; Brunner DB; Curtet AL; Turini GA; Gavras H
    Hypertension; 1980; 2(2):236-42. PubMed ID: 6247269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation between in vivo and in vitro measurements of converting enzyme activity after chronic oral treatment with captopril in rats.
    Unger T; Hübner D; Schüll B; Yukimura T; Rascher W; Lang RE; Ganten D
    Am J Cardiol; 1982 Apr; 49(6):1530-2. PubMed ID: 6280482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of captopril on rat aortic angiotensin-converting enzyme.
    Velletri P; Bean BL
    J Cardiovasc Pharmacol; 1982; 4(2):315-25. PubMed ID: 6175817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats.
    Unger T; Kaufmann-Bühler I; Schölkens B; Ganten D
    Eur J Pharmacol; 1981 Apr; 70(4):467-78. PubMed ID: 6263638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
    Unger T; Yukimura T; Marin-Grez M; Lang RE; Rascher W; Ganten D
    Eur J Pharmacol; 1982 Mar; 78(4):411-20. PubMed ID: 6281036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
    Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
    Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of central angiotensin I conversion by oral captopril.
    Marson O; Ribeiro AB; Tufik S; Kohlmann O; Ramos OL
    Braz J Med Biol Res; 1981 Apr; 14(1):73-6. PubMed ID: 6272920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo comparison of the renin inhibitor H77 with the angiotensin-converting enzyme inhibitor captopril.
    Oldham AA; Arnstein MJ; Major JS; Clough DP
    J Cardiovasc Pharmacol; 1984; 6(4):672-7. PubMed ID: 6206324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Converting enzyme inhibition and modulation of plasma renin activity with captopril in anesthetized rats.
    Suzuki M; Satoh S
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):121-36. PubMed ID: 6275810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of acute hemodynamic effects of MC-838, a new angiotensin-converting enzyme inhibitor, with captopril in anesthetized dogs.
    Noguchi K; Kato T; Sunagawa R; Miyamoto Y; Sakanashi M
    Jpn J Pharmacol; 1986 Mar; 40(3):373-80. PubMed ID: 3012164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
    Baum T; Becker FT; Sybertz EJ
    Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and pharmacology of angiotensin converting enzyme inhibitors.
    Antonaccio MJ
    J Pharmacol; 1983; 14 Suppl 3():29-45. PubMed ID: 6323887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of the hypotensive action of SQ-14225, an angiotensin-converting enzyme inhibitor in anesthetized dogs.
    Jandhyala BS; Nandiwada P; Buckley JP; Lokhandwala MF
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):429-46. PubMed ID: 228363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats.
    Rubin B; Antonaccio MJ; Goldberg ME; Harris DN; Itkin AG; Horovitz ZP; Panasevich RE; Laffan RJ
    Eur J Pharmacol; 1978 Oct; 51(4):377-88. PubMed ID: 213296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.